- 英文名称Xylenol Orange Tetrasodium Salt, Ind
- 中文名称二甲酚橙四钠盐,IND
- IUPAC名称sodium 2,2',2'',2'''-((((1,1-dioxido-3H-benzo[c][1,2]oxathiole-3,3-diyl)bis(6-hydroxy-5-methyl-3,1-phenylene))bis(methylene))bis(azanetriyl))tetraacetate
- 其它别名二甲酚橙四钠盐; 二甲苯酚橙钠盐, ; 二甲酚橘四钠盐; 二甲酚桔黄,二甲酚橙; 3,3′-双[n,N-双(羧甲基)氨基甲基]-邻甲酚磺酰酞 四钠盐; 二甲酚橙四钠盐, 指示剂; 二甲酚橙四钠盐, ; 二甲苯酚橙四钠盐; 二甲苯酚橙钠盐, 0.1% W/v 水溶液
- CAS编号3618-43-7
- MFCD编号:MFCD00044293
- EINECS号:222-805-8
- FDA UNII编号:0549U815B1
- 分子式:C31H32N2NaO13S
- 分子量:760.58
- 产品CID: 1371086
- 产品分类有机原料→生命科学→生化试剂→荧光探针,标记,染色
相似化合物
1611-35-4 1945-77-3 62625-29-0海关参考信息
- 2902300000-甲苯
2906210000-苄醇
2912110000-甲醛
2912120000-乙醛 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-12007376-B2
优先权日:2014-02-26
标题 :Method for determining a concentration of a synthesis component in a radiopharmaceutical sample
发明人:LEBEDEV ARTEM Y; ELIZAROV ARKADIJ M
权利人:TRACE ABILITY INC
摘要:A method for determining a concentration of a synthesis component in a radiopharmaceutical sample comprises providing an indicator, a metal or a metal complex, contacting the radiopharmaceutical sample with the indicator, metal or metal complex for a period of time sufficient to obtain an interaction, measuring an optical characteristic of the interacted components, and determining a concentration of the synthesis component in the radiopharmaceutical sample based on the measured optical characteristic.
专利号:US-10309947-B2
优先权日:2013-02-27
标题:System and method for radiosynthesis, quality control and dose dispensing
发明人:ELIZAROV ARKADIJ; LEBEDEV ARTEM
权利人:TRACE ABILITY INC
摘要:A system and method for performing radiochemical synthesis, analysis and/or dispensing of radiopharmaceuticals using specially designed disposable components: palettes and caddies, the palette being an assembly of containers not connected with each other for direct material transfer; the caddy being a disposable component used to transfer material between containers on the palettes and/or other locations.
专利号:US-2021102929-A1
优先权日:2014-02-26
标题:Method for determining a concentration of a synthesis component in a radiopharmaceutical sample